P Seetharamulu

Title: P Seetharamulu: Innovator in Cancer Treatment

Introduction

P Seetharamulu is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment options. His innovative work focuses on novel derivatives of camptothecin, a compound known for its potential in cancer therapy.

Latest Patents

P Seetharamulu holds 1 patent for his invention titled "Highly lipophilic camptothecin derivatives." This invention relates to novel derivatives of camptothecin, specifically those with substitutions at the C-7 position or at one of the C-9, C-10, C-11, or C-12 positions. The invention also encompasses disubstituted derivatives with a first substitution at C-7 and a second at one of the C-9, C-10, C-11, or C-12 positions. Furthermore, it includes methods for using these compounds as Topoisomerase I inhibitors to treat patients with cancer. The invention also covers pharmaceutical formulations consisting of these novel compounds in solution or suspension with one or more pharmaceutical excipients or diluents.

Career Highlights

P Seetharamulu is associated with Bionumerik Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective cancer treatments.

Collaborations

He has collaborated with notable colleagues, including Frederick H Hausheer and Kochat Haridas, contributing to a dynamic research environment that fosters innovation.

Conclusion

P Seetharamulu's contributions to the field of cancer treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to inspire advancements in medical science.